The NHS and Horizon seizing the opportunities Michael Wood, 18 December

NHS European Office Who are we? –Established 2007 –Part of the NHS Confederation –Funded by national NHS bodies What do we do? –Represent NHS organisations in EU policy-making and legislation –Assist the NHS with the implementation of EU law –Offer strategic advice on EU funding opportunities –Promote partnerships between NHS organisations and bodies from other sectors/countries.

EU funding - What we are doing to help NHS European Office bringing together key partners across sectors: Technology Strategy Board, including range of National Contact Points in relevant areas Medical Research Council Universities UK Research Councils UK Local Enterprise Partnerships European Commission Publications, webinars, events, intelligence sharing, presentations, facilitating meetings, representing…

EU funding - What we are doing to help The NHS European Office can assist NHS organisations wishing to apply for EU funds. We can: look at a project concept note and help assess whether it would be a potential fit for European funding support your organisation in establishing appropriate European partnerships help answer technical and administrative questions help develop capacity in your organisation to apply for and manage EU funds

What we will cover The NHS and FP7 Facts, figures and folklore Looking ahead to Horizon 2020 Innovation in the NHS Linking up health, academia and industry New players in the game

Participants landscape (UK) – academia and NHS FP7 Health – where was the NHS? %

Strong acute/specialist focus BUT scope for more...

FP7 Health – where was the NHS? NHS thematic experience is broad, but reoccurring subjects: chronic conditions; such as cancer, heart conditions, diabetes clinical trials paediatrics Ageing, including ICT/eHealth mental health (including Dementia, Parkinson’s etc) Strong biomedical focus BUT scope for more...

FP7 Health – where was the North West? A glance at the North West experience: clinical trials – esp around cancer but also rare diseases genetic testing research of existing technologies in clinical areas organ transplantation public health – nutrition, urban health indicators chronic conditions – hearing loss, diabetes patient safety - in primary care assisted living Very strong academic focus but some NHS trusts involved AND a European Reference Site!

My thoughts on NHS and FP7 Interest mainly confined to teaching hospitals and specialist providers – esp clinical Lack of real knowledge at NHS board level Clinical input often led through associated academic institutions Episodic interest on specific issues rather than wider focus on what matters for organisational strategy Limited appetite for the ‘long haul’ Even where NHS has been involved do we know about it? And yet NHS partners often actively sought across Europe

But benefits of collaboration are well known Participation in an EU-funded project can: complement local NHS initiatives with match-funding improve service delivery through information-sharing and exchange of good practice develop pan-European research networks benchmark and compare NHS practice with partners from other EU member states showcase the organisation’s achievements in a specific field or topic to international colleagues profile local, regional and national NHS innovations at international events attract world-class researchers to the organisation.

Horizon 2020– why should it be any different?

The burning platform Growing population with an extending lifespan; An increase in the NHS’ own capability though advances in knowledge, science and technology; Increasing expectation from the public; AND Flat cash settlements. Efficiency savings of c£5bn per annum until

The future isn’t bright "...this tight fiscal picture and the deep cuts seen by other departments make it likely that NHS funding will not increase over this period. We have estimated that this will lead to a further funding gap of around £30 billion by 2021/22... Continuing to deliver an annual 4% saving through 2019 will be challenging for every part of the NHS and will probably not be possible". Anita Charlesworth, Chief Economist, Nuffield Trust

What’s new? “Our ambition must be for an NHS defined by its commitment to innovation, demonstrated both in its support for research and its success in the rapid adoption and diffusion of the best, transformative, most innovative ideas, products, services and clinical practice” Sir David Nicholson, Chief Executive of the NHS in England

Clinical Commissioning Groups Acute NHS Trusts Mental Health Trusts Community Service Trusts Ambulance Trusts Local Education and Training Boards And bring others in to our work... Universities Local Authorities SME/industry representatives Other established networks What if we could pull together the NHS

Along a list of key priority areas? Ageing Information & Big data Well-being Social innovation Clinical trials Bio-science Medtech Life Sciences Chronic conditions Community-based healthcare New clinical pathways Preventative care

Then we can start driving innovation where we most need it

Regional collaboration Given emphasis on collaboration in Horizon 2020, there is potential key role for AHSNs as a coordinator: Can help to align priorities and ways of working before seeking European partners Mapping of assets can help with partner searches Help ensure the products of H2020 projects are tested/rolled out/used Knowledge of experience and interests across a region captured and accessible Entry point for industry and SMEs with ideas and enquiries from Europe A forum for intelligence sharing

A national perspective NHS Reforms created several new NATIONAL NHS bodies: –NHS England –Public Health England –Health Education England –Health and Social Care Information Centre All new, but all keen to engage in EU funding programmes where appropriate Very strong reputations/resources – would make good partners!

Looking ahead – the NHS and Horizon 2020 Number of reasons why scope for NHS engagement for is greater than previously: Burning platform facing health and social care EU innovation agenda fits well with Innovation, Health and Wealth Greater focus in Horizon 2020 on commercialisation Horizon 2020 brings together several EU programmes and simplifies rules EC keen to bring wider range of stakeholders together – collaboration the key Inward investment critical to wealth creation agenda

Getting started There are NHS experts in EU research funding out there – can you find them and use them now? Teaching hospitals/specialist providers good place to start – success breeds success Explore EVERY bit of Horizon 2020 There may be domestically funded projects that can be taken to EU level – eg TSB DALLAS projects Utilising our relationships with the academic sector, can we align priority areas to focus on – with an eye to commercialisation and the product! Offer to SME groups – are we in a position to facilitate interactions with range of NHS members What has been funded before? Can we learn from it? Speak to LEPs – they have identified Horizon 2020

Remember the other programmes!

Wrapping up Past experience has shown NHS can benefit from EU funding Innovation now at heart of what NHS is doing – we need to look at all possibilities to help bring change Much better cohesion with Industry and Academia needed Opportunities for new ideas to be tested, adopted and spread - at scale and pace A regional footprint - sharing experience and understanding, leading and coordinating National bodies prepared to get involved